Type I but Not Type II Calreticulin Mutations Activate the IRE1a/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms.

Type I but Not Type II Calreticulin Mutations Activate the IRE1a/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms. Blood Cancer Discov. 2022 07 06; 3(4):298-315.

View in: PubMed

subject areas

Calcium
Calreticulin
Endoribonucleases
Humans
Mutant Proteins
Mutation
Myeloproliferative Disorders
Neoplasms
Unfolded Protein Response
X-Box Binding Protein 1

authors with profiles

Scott Oakes
Sandeep Gurbuxani